IOVANCE BIOTHERAPEUTICS, INC.
IOVANCE BIOTHERAPEUTICS, INC.
SAN CARLOS, CA
Loading...
Price History
Market Data
| Market Cap | 1.63B |
| P/E Ratio | - |
| P/B Ratio | 2.33 |
| EPS | - |
| Dividend Yield | - |
| D/E Ratio | 0.31 |
| Current Ratio | 3.20 |
| Currency | USD |
Key Financial Metrics
263.50M
Revenue
-390.98M
Net Income
-
EPS (Diluted)
-630.96M
Free Cash Flow
Profitability
Gross Margin
28.7%
Operating Margin
-153.1%
Net Profit Margin
-148.4%
EBITDA
-384.31M
Returns & Efficiency
Return on Assets (ROA)
-42.8%
Return on Equity (ROE)
-56.0%
Dividend Yield
-
EPS
-
Financial Health
Total Assets
913.17M
Total Debt
-
Debt to Equity
0.31x
Current Ratio
3.20
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | SAN CARLOS, CA |
| Fiscal Year | 2025 |
Peers
AMGEN INC
AMGN
177.13B
P/E: --
GILEAD SCIENCES INC
GILD
166.13B
P/E: --
166.13B
P/E: --
BIOGEN IDEC INC.
BIIB
27.90B
P/E: --
BIOGEN INC.
BIIB
27.90B
P/E: --
19.11B
P/E: --
MODERNA, INC.
MRNA
18.38B
P/E: --
Moderna, Inc.
MRNA
18.38B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$1.63B
P/E Ratio (TTM)-
Price to Book2.33
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin28.7%
Operating Margin-153.1%
Net Margin-148.4%
ROE-56.0%
ROA-42.8%
Leverage & Liquidity
Debt to Equity0.31
Current Ratio3.20
Total Debt-
Total Assets$913.17M
Stockholders' Equity$698.58M
Income Statement (FY 2025)
Revenue$263.50M
Gross Profit$75.51M
Operating Income$-403.36M
Net Income$-390.98M
EPS (Diluted)-
Cash Flow (FY 2025)
Free Cash Flow$-630.96M
Cash & Equivalents$163.08M
Revenue Growth60.6%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS, CA 94070 |
| Phone | 6502607120 |
| Incorporated | DE, US |
| EIN | 753254381 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 411.96M |
| Stockholders' Equity | $698.58M |
| Cash & Equivalents | $163.08M |
Recent Filings
View All
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-28
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-04-28
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-26
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-24
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-02-24
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | IOVANCE BIOTHERAPEUTICS, INC. |
| Ticker | IOVA |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | SAN CARLOS, CA |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 1.63B |
| Revenue | 263.50M |
| Net Income | -390.98M |
| P/E Ratio | - |
| EPS | - |
| Net Margin | -148.4% |
| ROE | -56.0% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...